Laser induces apoptosis and ceramide production in human retinal pigment epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 7, 2005, Pages 2587-2591

  Barak, Adiel ^a,b   Goldkorn, Tzipora ^a   Morse, Lawrence S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DIACYLGLYCEROL KINASE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; ANNEXIN;

APOPTOSIS; ARTICLE; DIODE LASER; ENERGY; HUMAN; HUMAN CELL; LASER COAGULATION; LASER SURGERY; NICK END LABELING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RADIATION EXPOSURE; THIN LAYER CHROMATOGRAPHY; TIME; BIOSYNTHESIS; CELL LINE; INJURY; METABOLISM; PATHOLOGY;

ANNEXINS; APOPTOSIS; CELL LINE; CERAMIDES; CHROMATOGRAPHY, THIN LAYER; HUMANS; IN SITU NICK-END LABELING; LASER COAGULATION; PHOSPHATIDYLSERINES; PIGMENT EPITHELIUM OF EYE;

EID: 23244463224     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0920     Document Type: Article

References (51)

1. Fowler BJ. Accidental industrial laser burn of macula. Ann Ophthalmol. 1983;15:481-483.
2. Stuck BE, Zwick H, Molchany JW, Lund DJ. Accidental human laser retinal injuries from military laser systems. SPIE. 1996;2674:7-20.
3. Wolbarsht ML. Permanent blindness from laser exposure in laboratory and industrial accidents. SPIE. 1996;2674:21-24.
4. Haifeng L, Guanghuang G, Dechang W. Ocular injuries from accidental laser exposure. Health Phys. 1989;56:711-716.
5. Mellerio J, Marshall J, Tegroth B, Anderberg B, Wolbrasht M. Battlefield laser weapons: an assessment of systems, hazards, injuries and ophthalmic resources required for treatment. Laser Light Ophthalmol. 1991;4:41-67.
6. The Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol. 1991;109:1242-1257.
7. Brancato R, Pece A, Avanza A, Radrizzani E. Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia. Retina. 1991;10:239-243.
8. Dastgheib K, Bressler SB, Green WR. Clinicopathologic correlation of laser lesion expansion after treatment of choroidal neovascularization. Retina. 1993;13:345-352.
9. Rutledge BK, Wallow IH, Poulsen GL. Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema. Arch Ophthalmol. 1993;111:608-613.
10. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:44-56.
11. Whyte M, Evan G. The last cut is the deepest. Nature. 1995;376: 17-18.
12. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Noore A, Asnkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem. 1996;271: 12687-12690.
13. Wu X, Fan Z, Masui H, Rosen N, Mendelsohn J. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest. 1995;95:1897-1905.
14. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274:1855-1859.
15. Merrill JAH, Jones DD. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta. 1990; 1044:1-12.
16. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science. 1993;259:1769-1771.
17. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S. Induction of apoptotic DNA degradation and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA. 1994;91:73-77.
18. Andrieu N, Salvayre R, Jaffrezou JP, Levade T. Low temperatures and hypertonicity do not block cytokine-induced stimulation of the sphingomyelin pathway, but inhibit nuclear factor-kappa B activation. J Biol Chem. 1995;270:24518-24524.
19. Kim MY, Linardic C, Obeid L, Hannun Y. Identification of sphingomyelin turnover as an effector mechanism in the action of tumor necrosis factor alpha and gamma-interferon: specific role in cell differentiation. J Biol Chem. 1991;266:484-489.
20. Cifone MG, De Maria R, Roncaioli P, et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med. 1994;180:1547-1552.
21. Tepper CG, Jayadev S, Liu B, et al. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA. 1995;92:8443-8447.
22. Martin SJ, Newmeyer DD, Mathias S, et al. Cell-free reconstitution of Fas, UV radiation, and ceramide-induced apoptosis. EMBO J. 1995;14:5191-5200.
23. Boucher LM, Wiegmann K, Fiittere A, et al. CD28 signals through acidic sphingomyelinase. J Exp Med. 1995;181:2059-2068.
24. Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996;380:75-79.
25. Haimovitz-Friedman A, Kan C, Ehleiter D, et al. Radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med. 1994;180:525-535.
26. Santana P, Pena IA, Haimovitz-Friedmann A, et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 1996;86:189-199.
27. Strum JC, Small GW, Pauig SB, Daniel LW. 1-beta-D-Arabinofurano- sylcytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem. 1994;269:15493-15497.
28. Jaffrezou JP, Levade T, Betta Yeb A, et al. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J. 1996;15:2417-2424.
29. Barak A, Morse LS, Goldkorn T. Ceramide: a potential mediator of apoptosis in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2001;42:247-254.
30. Dunn KC, Aoktaki-Keen AE, Putkey FR, Hjelmeland LK. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
31. Gorczyca W, Gong J, Darzyukiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 1993;53:1945-1951.
32. Oberhammer FA, Pavelka M, Sharma S, et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci USA. 1992;89:5408-5412.
33. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Exp Cell Res. 1994;214: 242-249.
34. Balaban N, Moni J, Dang L, Goldkorn T. Effects of radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim Biophys Acta. 1996;1314:147-156.
35. Goldkorn T, Muindi J, Radin NS, Menaldino D, Liotta D, Kolesnick RN. Ceramide stimulates EGF receptor phosphorylation in A431 human epidermoid carcinoma cells: evidence that ceramide mediates sphingosine action. J Biol Chem. 1992;266:16092-16097.
36. Hetts SW. To die or not to die: an overview of apoptosis and its role in disease (review). JAMA. 1998;279:300-307.
37. Barkana Y, Belkin M. Laser eye injury. Surv Ophthalmol. 2000;44: 459-478.
38. Arkin WM. Vienna meeting sets ban on blinding laser weapons. Laser Focus World. 1995;December:62-64.
39. Mader TH, Aragones JV, Chandler AC, et al. Ocular and ocular adnexal injuries treated by United States military ophthalmologists during Operations Desert Shield and Desert Storm. Ophthalmology. 1993;100:1462-1467.
40. Gorsuch GM. Laser injury. Navy Med. 1996;23-26.
41. Lam TT, Takahashi K, Fu J, Tso MO. Methylprednisolone therapy in laser injury of the retina. Graefes Arch Clin Exp Ophthalmol. 1993;231:729-736.
42. Takahashi K, Fu J, Lam TT, Tso MO. The effect of high-dose methylprednisolone on laser-induced retinal injury primates: an electron microscope study. Graefes Arch Clin Exp Ophthalmol. 1997; 4:35-39.
43. Rosner M, Turetz J, Solberg Y, Belkin M. Neuroprotective therapy for argon laser induced retinal injury. Exp Eye Res. 1997;65:485-495.
44. Solberg Y, Rosner M, Turetz J, Belkin M. MK-801 has neuroprotective and antiproliferative effect in retinal laser injury. Invest Ophthalmol Vis Sci. 1997;38:1380-1389.
45. Jayadev S, Liu B, Bielawska AE, et al. Role for ceramide in cell cycle arrest. J Biol Chem. 1995;270:2047-2052.
46. Dressier KA, Mathias S, Kolesnick RN. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science. 1992;27:255:1715-1718.
47. Liu J, Mathias S, Yang Z, Kolesnick RN. Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem. 1994;269:3047-3052.
48. Andrieu N, Salvayre R, Levade T. Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem J. 1994;303:341-345.
49. Cremesti AE, Fischl AS. Current methods for the identification and quantitation of ceramides: an overview. Lipids. 2000;35:937-945.
50. Thomas RL Jr, Matsko CM, Lotze MT, Amoscato AA. Mass spectrometric identification of increased C16 ceramide levels during apoptosis. J Biol Chem. 1999;274:30580-30588.
51. Lamba OP, Lal S, Yappert MC, Lou MF, Borchman D. Spectroscopic detection of lipid peroxidation products and structural changes in a sphingomyelin model system. Biochem Biophys Acta. 1991; 1081:181-187.